Thermogenesis Holdings to Participate at the H.C. Wainwright BIOCONNECT 2021 Conference
RANCHO CORDOVA, Calif., Jan. 7, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Jeff Cauble, Chief Financial Officer, will present a company overview at the H.C. Wainwright BIOCONNECT 2021 Conference.
The presentation will be available beginning January 11, at 6:00 am ET, on the ThermoGenesis website at: https://thermogenesis.com/investors/news-and-events/events-webcasts and will be archived for a period of 90 days after the conference.
About ThermoGenesis Holdings, Inc.
SOURCE ThermoGenesis Holdings, Inc.
Company Codes: NASDAQ-NMS:THMO